Does antiarrhythmic drugs premedication improve electrical cardioversion success in persistent atrial fibrillation?

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Aim of this study is to evaluate the impact of antiarrhythmic drugs (AADs) administration for at least one month before ECV on the acute and long term success rate of the procedure.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Electrocardiol

Title: Journal of electrocardiology

Publisher: Elsevier BV

ISSN (Electronic): 1532-8430

ISSN (Print): 0022-0736

Publication date (Electronic): January 11 2017

Volume: 50

Issue: 3

Affiliations

[1 ] Division of Cardiology, Department of Medical Sciences, Città della salute e della scienza, University of Turin, Turin, Italy.

[2 ] Division of Cardiology, Department of Medical Sciences, Città della salute e della scienza, University of Turin, Turin, Italy. Electronic address: mario.iannaccone@hotmail.it.

[3 ] Division of Cardiology, Department of Internal Medicine, Cardinal Massaia Hospital, Asti, Italy.

[4 ] Department of Cardiology and Cardiovascular Surgery, San Giuseppe Moscati Hospital, Avellino, Italy.

Article

Publisher Item ID: S0022-0736(16)30330-2

DOI: 10.1016/j.jelectrocard.2016.12.004

PubMed ID: 28069273

SO-VID: a8da51ad-f2a8-4dd2-a3f7-5556af080e8b

History

Keywords: Antiarrhythmic drugs,Atrial fibrillation,Electrical cardioversion

Data availability:

Keywords: Antiarrhythmic drugs, Atrial fibrillation, Electrical cardioversion

Comments

Comment on this article

scite_

Cited by 4

See all cited by